GT
46
3
VNO
59
3
TRIP
60
3
LB
41
-11
SYK
57
-2
APD
42
-2
WYNN
34
-3
NUE
50
3
INTU
60
-3
MCK
46
-3
VRSN
50
-5
PYPL
45
-2
MSFT
54
-3
ICE
64
-5
JNJ
51
-2
FTI
69
-7
ABT
57
-9
INTC
37
-4
TJX
50
2
PPL
60
-7
GT
46
3
VNO
59
3
TRIP
60
3
LB
41
-11
SYK
57
-2
APD
42
-2
WYNN
34
-3
NUE
50
3
INTU
60
-3
MCK
46
-3
VRSN
50
-5
PYPL
45
-2
MSFT
54
-3
ICE
64
-5
JNJ
51
-2
FTI
69
-7
ABT
57
-9
INTC
37
-4
TJX
50
2
PPL
60
-7
Financhill
Back

Corcept Therapeutics Quote, Financials, Valuation and Earnings

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
68

CORT
Corcept Therapeutics

Last Price:
41.46
Seasonality Move:
-0.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market

Corcept Therapeutics Price Quote

$41.46
-0.81 (-1.92%)
(Updated: September 19, 2024 at 3:00 PM ET)

Corcept Therapeutics Key Stats

Buy
68
Corcept Therapeutics (CORT) is a Buy
Day range:
$40.15 - $43.32
52-week range:
$20.84 - $43.32
Dividend yield:
0%
P/E ratio:
44.97
P/S ratio:
8.22
P/B ratio:
7.41%
Volume:
2M
Avg. volume:
627.2K
1-year change:
30.79%
Market cap:
$4.4B
Revenue:
$482.4M
EPS:
$1.13

How Much Does Corcept Therapeutics Make?

Is Corcept Therapeutics Growing As A Company?

  • What Is Corcept Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.39%
  • What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.28%

Corcept Therapeutics Stock Price Performance

What Is Corcept Therapeutics 52-Week High & Low?

Corcept Therapeutics Price To Free Cash Flow

Is It Risky To Buy Corcept Therapeutics?

Is Corcept Therapeutics Cash Flow Positive?

  • What Is CORT Cash Flow From Operations?
    Cash flow from operations (TTM) is $123.7M
  • What Is Corcept Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.8M
  • What Is Corcept Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$161.7M

Corcept Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CORT return on invested capital is 24.86%
  • What Is Corcept Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 20.25%
  • What Is CORT Return On Equity?
    ROE is a measure of profitability and is 24.86%

Corcept Therapeutics Earnings Date & Stock Price

Corcept Therapeutics Competitors

Corcept Therapeutics Dividend Yield

Corcept Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 28% 34.74%
Revenue: 39.15% 5.53%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 65.40
Upside from Last Price: 54.72%

Major Shareholders

  • How many CORT shares are owned by institutional investors?
    131M CORT shares are owned by institutional investors
  • How many CORT shares are owned by insiders?
    8.5M CORT shares are owned by insiders